CPC A61K 39/118 (2013.01) [A61P 31/04 (2018.01); G01N 33/56927 (2013.01); A61K 2039/521 (2013.01); G01N 2800/26 (2013.01)] | 12 Claims |
1. A method of protecting against infections caused by Chlamydia bacteria selected from the group consisting of Chlamydia muridarum, Chlamydia pneumoniae, Chlamydia psitacci, Chlamydia abortus, Chlamydia felis, Chlamydia caviae, Chlamydia pecorum, Chlamydia suis and Chlamydia trachomatis, comprising:
administering to a subject a composition comprising an immunogenic dose of an inactivated β-lactam-treated form of Chlamydia bacteria selected from the group consisting of Chlamydia muridarum, Chlamydia pneumoniae, Chlamydia psitacci, Chlamydia abortus, Chlamydia felis, Chlamydia caviae, Chlamydia pecorum, Chlamydia suis and Chlamydia trachomatis,
wherein the inactivated β-lactam-treated form of Chlamydia bacteria has been previously inactivated by treating with a β-lactam.
|